Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

CERo Therapeutics Holdings, Inc. (CERO) vs Seelos Therapeutics, Inc. (SEELQ)

CERo Therapeutics Holdings, Inc. and Seelos Therapeutics, Inc. are both Biotechnology companies. Seelos Therapeutics, Inc. is the larger, with a market value of $700.0K against $140.0K — 5.0× the size. Seelos Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; CERo Therapeutics Holdings, Inc. trades at 0.0×. Seelos Therapeutics, Inc. has the higher net margin (203.1% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, CERo Therapeutics Holdings, Inc. leads on 6 and Seelos Therapeutics, Inc. on 5.

Valuation

Metric CERO SEELQ Biotechnology median
P/E 0.00 n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 0.50 10.73
Earnings yield 300,221.00% 0.00% (28.84%)
Free cash flow yield (2,869.14%) 0.00% (23.03%)

Profitability

Metric CERO SEELQ Biotechnology median
Gross margin — 100.00% 65.16%
Operating margin 0.00% (1,480.04%) 0.00%
Net margin 0.00% 203.13% 0.00%
Free cash flow margin 0.00% (659.09%) 0.00%
Return on equity 453.76% (10.86%) (57.72%)
Return on assets (2,352.32%) 57.34% (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CERO SEELQ Biotechnology median
Revenue growth (TTM) — (51.45%) 5.64%
EPS growth (last fiscal year) 92.12% 62.72% —
Revenue growth, 5-year CAGR — (22.63%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CERO SEELQ Biotechnology median
Debt to equity (0.02) 0.00 0.00
Current ratio 0.05 0.08 4.73
Net debt to EBITDA 0.10 0.09 0.96

Dividend

Metric CERO SEELQ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CERO SEELQ Biotechnology median
Market cap 140.00k 700.00k 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack